|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000040933 |
Summary for INPP4A |
Gene summary |
| Gene information | Ensembl ID | ENSG00000040933 | Gene symbol | INPP4A |
| Gene name | inositol polyphosphate-4-phosphatase type I A | |
| HGNC | 6074 | |
| Entrez ID | 3631 | |
| Gene type | protein_coding | |
| Synonyms | INPP4A| | |
| UniProtAcc | Q96PE3 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for INPP4A |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for INPP4A |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for INPP4A |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| ESCA | cg16469046 | chr2:98446536 | CGI:chr2:98444711-98445385 | promoter,gene body | 7.78e-01 | 6.57e-01 | 2.03e+00 | 4.28e-02 | 4.76e-02 | 1.20e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for INPP4A |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| KICH | exon_skip_327960 | 8.59e-01 | 9.68e-01 | -2.99e+00 | 2.82e-03 | 9.40e-03 | -1.09e-01 |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for INPP4A |
| ∗Please access CAeditome for RNA editing annotation. |
Landscape of RNA editing events across multiple cancer types. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| COAD | INPP4A-004 | chr2_98496643_+ | 2.84e-01 | 5.05e-01 | -2.74e+00 | 6.17e-03 | 1.72e-02 | -2.21e-01 |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for INPP4A |
TFs related to INPP4A.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | ZNF418 | INPP4A | 2.26e+00 | 5.69e-04 | 3.76e+00 | 9.81e-01 | Female-biased |
| BLCA | DMRT2 | INPP4A | 2.85e+00 | 1.04e-03 | 4.27e+00 | 9.88e-01 | Female-biased |
| BLCA | HOXA9 | INPP4A | 3.20e+00 | 3.32e-03 | 4.32e+00 | 9.87e-01 | Female-biased |
| BLCA | LHX9 | INPP4A | 3.06e+00 | 4.29e-03 | 4.11e+00 | 9.82e-01 | Female-biased |
| BLCA | NFIL3 | INPP4A | 3.82e+00 | 1.30e-02 | 4.61e+00 | 9.81e-01 | Female-biased |
| BLCA | ZNF334 | INPP4A | 1.78e+00 | 1.64e-05 | 4.24e+00 | 9.89e-01 | Female-biased |
| BLCA | ZNF418 | INPP4A | 8.92e-01 | 8.35e-07 | 4.23e+00 | 9.88e-01 | Female-biased |
| BLCA | ZNF79 | INPP4A | 1.74e+00 | 2.50e-05 | 4.10e+00 | 9.86e-01 | Female-biased |
| BLCA | ZNF879 | INPP4A | 1.21e+00 | 4.05e-06 | 4.06e+00 | 9.85e-01 | Female-biased |
| DLBC | ZNF418 | INPP4A | 4.29e+00 | 9.87e-01 | 3.18e+00 | 3.59e-03 | Male-biased |
| PAAD | ZNF334 | INPP4A | 4.29e+00 | 9.84e-01 | 3.37e+00 | 6.39e-03 | Male-biased |
| PAAD | ZNF79 | INPP4A | 4.15e+00 | 9.80e-01 | 3.27e+00 | 7.92e-03 | Male-biased |
| PCPG | ZNF418 | INPP4A | 4.73e+00 | 9.84e-01 | 3.96e+00 | 1.14e-02 | Male-biased |
| THYM | DMRT2 | INPP4A | 3.74e+00 | 9.96e-03 | 4.43e+00 | 9.81e-01 | Female-biased |
| THYM | FOXR2 | INPP4A | 3.43e+00 | 5.95e-03 | 4.24e+00 | 9.82e-01 | Female-biased |
| THYM | ZNF334 | INPP4A | 3.48e+00 | 2.63e-03 | 4.50e+00 | 9.89e-01 | Female-biased |
| THYM | ZNF418 | INPP4A | 3.76e+00 | 1.87e-03 | 4.87e+00 | 9.94e-01 | Female-biased |
| THYM | ZNF79 | INPP4A | 3.49e+00 | 5.17e-03 | 4.34e+00 | 9.84e-01 | Female-biased |
| THYM | ZNF879 | INPP4A | 3.48e+00 | 4.75e-03 | 4.35e+00 | 9.85e-01 | Female-biased |
INPP4A related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for INPP4A |
RBPs related to ES in INPP4A.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| KICH | KHDRBS2 | exon_skip_327953 | 8.00e+00 | 1.14e-02 | 8.31e+00 | 9.81e-01 | Female-biased |
| KICH | MBNL1 | exon_skip_327958 | 8.20e+00 | 1.14e-02 | 8.51e+00 | 9.82e-01 | Female-biased |
| KICH | SAMD4A | exon_skip_327960 | 8.13e+00 | 4.26e-03 | 8.53e+00 | 9.89e-01 | Female-biased |
| SKCM | ZC3H10 | exon_skip_327961 | 6.93e+00 | 9.84e-01 | 6.36e+00 | 1.41e-03 | Male-biased |
| HNSC | ZC3H10 | exon_skip_327961 | 7.01e+00 | 9.85e-01 | 6.37e+00 | 7.58e-04 | Male-biased |
INPP4A related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4622754 | chr2:100877757:G:C | - | -0.21300783680703 | 0.0052846454075104 | KIRP | Female-baised eQTL |
| rs2164319 | chr2:100879562:A:T | - | -0.191695189491349 | 0.0201855177815084 | KIRP | Female-baised eQTL |
| rs4851134 | chr2:98434183:A:C | - | 0.0739189135435383 | 0.0149143565406982 | LUAD | Female-baised eQTL |
| rs17031146 | chr2:98420220:A:G | - | 0.0640456423298133 | 0.0436241157454802 | LUAD | Female-baised eQTL |
| rs73945048 | chr2:105114397:G:A | - | -0.0806463364592351 | 0.00959649363635716 | COAD | Female-baised eQTL |
| rs12473201 | chr2:105124569:G:C | - | -0.0792310223154923 | 0.0121336673959258 | COAD | Female-baised eQTL |
| rs10185741 | chr2:105125216:T:C | - | -0.0792310223154923 | 0.0121336673959258 | COAD | Female-baised eQTL |
| rs4386344 | chr2:104943259:C:G | - | -0.0745786181526605 | 0.0144065357122798 | COAD | Female-baised eQTL |
| rs61159074 | chr2:105112474:G:A | - | -0.0764191146584305 | 0.0278051689406201 | COAD | Female-baised eQTL |
| rs73945047 | chr2:105112808:T:C | - | -0.0764191146584305 | 0.0278051689406201 | COAD | Female-baised eQTL |
| rs11687311 | chr2:105117389:T:G | - | -0.0759272374405882 | 0.0302355267267001 | COAD | Female-baised eQTL |
| rs6760606 | chr2:105119379:A:G | - | -0.07516562097625 | 0.0331170353291713 | COAD | Female-baised eQTL |
| rs7567068 | chr2:105125673:C:T | - | -0.07516562097625 | 0.0331170353291713 | COAD | Female-baised eQTL |
| rs4378828 | chr2:105129075:C:T | - | -0.07516562097625 | 0.0331170353291713 | COAD | Female-baised eQTL |
| rs12616980 | chr2:105130337:T:C | - | -0.0733526765794786 | 0.0388929999598281 | COAD | Female-baised eQTL |
| rs6721525 | chr2:105110449:G:A | - | -0.0743730078535036 | 0.0393471164702177 | COAD | Female-baised eQTL |
| rs4271787 | chr2:105114417:A:G | - | -0.0739354796716488 | 0.041731103163865 | COAD | Female-baised eQTL |
| rs4266037 | chr2:105114291:A:G | - | -0.0736886432512113 | 0.0428538205463609 | COAD | Female-baised eQTL |
| rs6719925 | chr2:105132388:C:G | - | -0.0725474172934109 | 0.0441019767774362 | COAD | Female-baised eQTL |
| rs7607395 | chr2:105135292:G:C | - | -0.0740104554411478 | 0.0448954260113802 | COAD | Female-baised eQTL |
| rs7597847 | chr2:105135066:T:C | - | -0.0752211503363992 | 0.0478967425411216 | COAD | Female-baised eQTL |
| rs3923277 | chr2:105120696:A:G | - | -0.0726492886842374 | 0.0493107050254376 | COAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs12622433 | chr2:106826913:C:A | - | 0.0396164529529986 | 0.0453925571714495 | LUSC | Male-baised eQTL |
| rs880596 | chr2:105022563:G:A | - | 0.0981571101524388 | 0.0139469068563762 | KIRC | Male-baised eQTL |
| rs880595 | chr2:105022723:T:A | - | 0.0981571101524388 | 0.0139469068563762 | KIRC | Male-baised eQTL |
| rs17030529 | chr2:105024478:A:G | - | 0.0981571101524388 | 0.0139469068563762 | KIRC | Male-baised eQTL |
| rs17030532 | chr2:105024644:C:A | - | 0.0981571101524388 | 0.0139469068563762 | KIRC | Male-baised eQTL |
| rs11674168 | chr2:100912702:C:T | - | 0.0719780183561368 | 0.0162446249988648 | KIRC | Male-baised eQTL |
| rs7565174 | chr2:106832865:A:T | - | -0.0596165082857308 | 0.0166294968675471 | KIRC | Male-baised eQTL |
| rs114253203 | chr2:105025945:G:A | - | 0.0985642183559918 | 0.0171889416135781 | KIRC | Male-baised eQTL |
| rs74884393 | chr2:105026150:T:C | - | 0.0985642183559918 | 0.0171889416135781 | KIRC | Male-baised eQTL |
| rs1978649 | chr2:105031875:C:T | - | 0.0985642183559918 | 0.0171889416135781 | KIRC | Male-baised eQTL |
| rs1972744 | chr2:105033221:C:T | - | 0.0985642183559918 | 0.0171889416135781 | KIRC | Male-baised eQTL |
| rs78898895 | chr2:105034578:T:G | - | 0.0985642183559918 | 0.0171889416135781 | KIRC | Male-baised eQTL |
| rs78083006 | chr2:105037948:C:G | - | 0.0985642183559918 | 0.0171889416135781 | KIRC | Male-baised eQTL |
| rs79407521 | chr2:105040710:A:C | - | 0.0985642183559918 | 0.0171889416135781 | KIRC | Male-baised eQTL |
| rs7581671 | chr2:105027690:G:C | - | 0.0956472350225438 | 0.0174779789479396 | KIRC | Male-baised eQTL |
| rs116553406 | chr2:105028723:G:A | - | 0.0956472350225438 | 0.0174779789479396 | KIRC | Male-baised eQTL |
| rs201829844 | chr2:105026384:T:G | - | 0.0962867399761492 | 0.0181722636350996 | KIRC | Male-baised eQTL |
| rs1052431 | chr2:102718510:G:A | - | 0.0470366631001523 | 0.0183282285077936 | KIRC | Male-baised eQTL |
| rs2198200 | chr2:105701104:C:T | - | 0.0814383113183603 | 0.0257332765058577 | KIRC | Male-baised eQTL |
| rs75320233 | chr2:105704249:C:T | - | 0.078643478064244 | 0.0263891631505806 | KIRC | Male-baised eQTL |
| rs2198201 | chr2:105701125:G:C | - | 0.0791839487409431 | 0.0282945531581121 | KIRC | Male-baised eQTL |
| rs1823646 | chr2:105701812:A:G | - | 0.0784904679470247 | 0.0290842838708745 | KIRC | Male-baised eQTL |
| rs56323138 | chr2:105702129:A:G | - | 0.0784904679470247 | 0.0290842838708745 | KIRC | Male-baised eQTL |
| rs7557667 | chr2:107336101:T:G | - | -0.0578763441790656 | 0.0358530604003642 | KIRC | Male-baised eQTL |
| rs6751196 | chr2:98750023:G:A | - | 0.0639521653519789 | 0.0376086750166303 | KIRC | Male-baised eQTL |
| rs4438501 | chr2:105703039:T:C | - | 0.0756368721634415 | 0.0382562906395068 | KIRC | Male-baised eQTL |
| rs77233740 | chr2:105703190:A:G | - | 0.0756368721634415 | 0.0382562906395068 | KIRC | Male-baised eQTL |
| rs80215128 | chr2:105703246:C:T | - | 0.0756368721634415 | 0.0382562906395068 | KIRC | Male-baised eQTL |
| rs77737299 | chr2:105704149:A:G | - | 0.0756368721634415 | 0.0382562906395068 | KIRC | Male-baised eQTL |
| rs76951342 | chr2:105704340:G:A | - | 0.0756368721634415 | 0.0382562906395068 | KIRC | Male-baised eQTL |
| rs79453276 | chr2:105704658:T:C | - | 0.0756368721634415 | 0.0382562906395068 | KIRC | Male-baised eQTL |
| rs79980492 | chr2:105704863:G:A | - | 0.0756368721634415 | 0.0382562906395068 | KIRC | Male-baised eQTL |
| rs78667907 | chr2:105704951:T:C | - | 0.0756368721634415 | 0.0382562906395068 | KIRC | Male-baised eQTL |
| rs79510501 | chr2:105705212:A:G | - | 0.0756368721634415 | 0.0382562906395068 | KIRC | Male-baised eQTL |
| rs74409320 | chr2:105705374:C:G | - | 0.0756368721634415 | 0.0382562906395068 | KIRC | Male-baised eQTL |
| rs77006260 | chr2:105705449:A:G | - | 0.0756368721634415 | 0.0382562906395068 | KIRC | Male-baised eQTL |
| rs55826612 | chr2:105705894:T:G | - | 0.0756368721634415 | 0.0382562906395068 | KIRC | Male-baised eQTL |
| rs79635055 | chr2:105706587:T:C | - | 0.0756368721634415 | 0.0382562906395068 | KIRC | Male-baised eQTL |
| rs75123121 | chr2:105706745:A:G | - | 0.0756368721634415 | 0.0382562906395068 | KIRC | Male-baised eQTL |
| rs1393001 | chr2:105708451:A:G | - | 0.0754906167138201 | 0.0389686620080726 | KIRC | Male-baised eQTL |
| rs13402012 | chr2:103064031:G:T | - | 0.0866213177305431 | 0.0253938396536842 | LUAD | Male-baised eQTL |
| rs12712163 | chr2:97846195:G:A | - | 0.070395013955444 | 0.00184156148753506 | COAD | Male-baised eQTL |
| rs6711763 | chr2:107928953:C:T | - | -0.0775314978957964 | 0.00208017846112281 | COAD | Male-baised eQTL |
| rs2576772 | chr2:105352117:C:G | - | -0.0609242072672534 | 0.00755626312807268 | COAD | Male-baised eQTL |
| rs10176869 | chr2:99815930:A:C | - | -0.0612210468391523 | 0.00795223278656749 | COAD | Male-baised eQTL |
| rs2310170 | chr2:101999692:T:G | - | 0.0587222715318391 | 0.0149744567956688 | COAD | Male-baised eQTL |
| rs2576774 | chr2:105355180:C:G | - | -0.0568130862221889 | 0.0186439091965952 | COAD | Male-baised eQTL |
| rs55896286 | chr2:102595060:C:G | - | 0.0614497187413817 | 0.0186496710573356 | COAD | Male-baised eQTL |
| rs2192667 | chr2:102595737:G:A | - | 0.0614497187413817 | 0.0186496710573356 | COAD | Male-baised eQTL |
| rs957404 | chr2:102596999:C:T | - | 0.0614497187413817 | 0.0186496710573356 | COAD | Male-baised eQTL |
| rs757918 | chr2:101996837:C:T | - | 0.0556477056697795 | 0.0194720662112825 | COAD | Male-baised eQTL |
| rs62152067 | chr2:102673390:T:C | - | 0.0751160346043625 | 0.0230505537816681 | COAD | Male-baised eQTL |
| rs13422113 | chr2:102682446:A:G | - | 0.070813480788292 | 0.0300198455012641 | COAD | Male-baised eQTL |
| rs11690974 | chr2:88483278:G:T | - | 0.0526181051310119 | 0.037975238483458 | COAD | Male-baised eQTL |
| rs6733320 | chr2:88482301:G:A | - | 0.0530581463317573 | 0.0409608059755645 | COAD | Male-baised eQTL |
| rs11127096 | chr2:88482370:G:A | - | 0.0530581463317573 | 0.0409608059755645 | COAD | Male-baised eQTL |
| rs61392151 | chr2:103090122:C:T | - | 0.122094732688109 | 0.0456827826342695 | COAD | Male-baised eQTL |
| rs58373952 | chr2:103092976:C:T | - | 0.122094732688109 | 0.0456827826342695 | COAD | Male-baised eQTL |
| rs905084 | chr2:105768278:G:A | - | 0.056315724925751 | 0.0467683517780142 | COAD | Male-baised eQTL |
| rs138228302 | chr2:103077843:C:T | - | 0.119831591407976 | 0.0469075603723731 | COAD | Male-baised eQTL |
| rs72998437 | chr2:103080857:T:G | - | 0.119831591407976 | 0.0469075603723731 | COAD | Male-baised eQTL |
| rs72998440 | chr2:103083085:A:G | - | 0.119831591407976 | 0.0469075603723731 | COAD | Male-baised eQTL |
| rs61063056 | chr2:103086083:G:T | - | 0.119831591407976 | 0.0469075603723731 | COAD | Male-baised eQTL |
| rs72998450 | chr2:103089454:G:T | - | 0.119831591407976 | 0.0469075603723731 | COAD | Male-baised eQTL |
| rs2170602 | chr2:103070068:C:T | - | 0.119548044277417 | 0.0479221859286402 | COAD | Male-baised eQTL |
| rs1123174 | chr2:103071208:G:A | - | 0.119548044277417 | 0.0479221859286402 | COAD | Male-baised eQTL |
| rs180684189 | chr2:103071874:C:T | - | 0.119548044277417 | 0.0479221859286402 | COAD | Male-baised eQTL |
| rs72998429 | chr2:103074016:A:G | - | 0.119548044277417 | 0.0479221859286402 | COAD | Male-baised eQTL |
| rs80085654 | chr2:102564653:T:A | - | 0.0597693178438226 | 0.0491842991842802 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg23882186 | chr2:98448958 | gene,enhancer | -0.319534196417166 | 2.10808280120556e-08 | -0.440821149796618 | 5.783151335370996e-11 | KIRP |
| cg20923498 | chr2:98480457 | gene | -0.319534196417166 | 2.10808280120556e-08 | -0.440821149796618 | 5.783151335370996e-11 | KIRP |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of INPP4A |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000040933 | INPP4A | C0020796 | Profound Mental Retardation | 1 | CTD_human |
| ENSG00000040933 | INPP4A | C0025363 | Mental Retardation, Psychosocial | 1 | CTD_human |
| ENSG00000040933 | INPP4A | C0917816 | Mental deficiency | 1 | CTD_human |
| ENSG00000040933 | INPP4A | C3714756 | Intellectual Disability | 1 | CTD_human |